Drug intelligence / Profile preview

Visionex

Development stage
Unknown
Lead developer
USANA Health Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Visionex is a specialized nutraceutical formulation developed by USANA Health Sciences, primarily indicated for the maintenance of long-term ocular health and the preservation of visual performance. The product's efficacy is derived from a synergistic blend of the macular carotenoids lutein and zeaxanthin, which are selectively deposited in the macula lutea of the eye. These compounds function as optical filters for high-energy blue light and as potent antioxidants that quench singlet oxygen and reduce lipid peroxidation in the photoreceptor outer segments. The inclusion of bilberry extract (rich in anthocyanosides), vitamin C, and zinc provides additional metabolic support and enhances the endogenous antioxidant defense system within the retinal pigment epithelium and the lens, helping to maintain macular pigment optical density (MPOD) and protect against age-related oxidative damage.

Brand names
VisionexVisionex DS
Other names
USANA Visionex
02

Targets

Misfolded SOD1

Beyond the preview

Go deeper on Visionex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visionex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call